Company / Capital Expenditures
Centessa Pharmaceuticals plc Capital Expenditures History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$371.0K
FY2025
5-year range
$34.0K / $1.1M
FY2021-FY2025
Trend
+991.2%
vs FY2024
Sector context
#145 of 195
Health Care
What the data says
Capital Expenditures changed +991% YoY in FY2025, a notable deviation from the 4-year average annual change of +334%.
Based on SEC 10-K filings.
$371,000 in FY2025 with a 3-year CAGR of -31.2%.
Improved from $169,000 to $371,000 over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -31.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#145 of 195 in Health CareTop 74% of 195This company $371.0K Sector average $116.9M
▼
-99.7% below sector average
Key checks
Key Insights
- 3-year CAGR of -31.2%, indicating a declining trend.
- In FY2025, capital expenditures increased 991.2% year-over-year.
- Ranks #145 out of 195 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $371.0K | +991.2% |
| FY2024 | $34.0K | -79.9% |
| FY2023 | $169.0K | -85.1% |
| FY2022 | $1.1M | +511.3% |
| FY2021 | $186.0K | - |
| FY2020 | $0 | - |
| FY2019 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026